Skip to content
Events

Person in hazmat suit producing radiopharmaceuticals
10 days to go

UK Digital Health Advisory Panel 2026

13 February 2026, 12:00 - 14:00 GMT+01:00

Webinar

Innovation Norway introduces the new UK Digital Health Advisory Panel: your gateway to opportunities in the UK market. Through three digital meet ups in 2026, Norwegian companies will get expert advice to help shape their growth strategies in the UK market.

  • Webinar 1: Market Entry and Qualification - Friday 13th February, 12-2pm Norwegian time. Participating advisors:

Jason Leitch CBE

Professor / Patient safety and Healthcare quality expert / Senior Fellow IHI / Former National Clinical Director Scotland

Nicola Haywood-Cleverly

NED | Strategic Advisor | Transformation Lead. FBCS | CHCIO | LPFEDIP | CEng | MIET | MBA

Michelle Tempest

Doctor/ Boardmember/ Investor/ Advisor/ Author/ Candesic Partner

Rhidian Hurle

CCIO Wales. Medical Director at Digital Health and Care Wales / Part time Consultant Urological Surgeon. Professor @UWTSD

  • Webinar 2: Advancing Early Interest and Securing the Offer - Friday 17th April, 12-2pm Norwegian time. Participating advisors:

Tony Bowden

CEO Helicon Health

Peter Gerber

Healthcare Consultant

Conor Burke

CEO UHUK / NED / Advisor

  • Webinar 3: Business Case and Procurement Readiness - Friday 5th June, 12-2pm Norwegian time. Participating advisors:

Kamal Lakhpuri

Director of Digital Informatics, East Genomic Medicine Service Alliance (GMSA) and Global Digital Health Project Assurance and Coordinator

Martin Bell

Healthcare, IT, Business Consultant

Thomas Webb

NHS Digital Leader | Founder & Former CEO | NED | EPR Usability Specialist

Who should attend:

Norwegian health and life science companies interested in export, collaboration or partnerships in UK and Ireland.

We expect companies to participate in all three meetings to get the full benefit of the programme. The topics and advisors are chosen to give you the best foundation to build a growth plan for the UK market.

Please note that there are limited spaces available for companies, this is to make sure each company get the follow up they need, and to keep the discussions and meetings dynamic. Please register interest and we will get back to you.

Programme highlights:

  • Work on strategy, growth plan or business case through the three meetings
  • Get expert advice and input on your company plan
  • Share learnings, knowledge, tips and tricks on growth and learn from other Norwegian companies
  • At the end of the three meetings companies will get a chance to pitch their plan and get feedback

About the panel:

As part of the Export Initiative on health Innovation Norway will facilitate three digital meetings with the advisory panel through 2026. Each meeting will include up to four advisors, selected according to their expertise and based on the needs of the Norwegian companies. Participating companies may follow up discussions individually with advisors at their own cost in between the meetings.

The main objectives of the panel include:

  • Providing expertise in key areas
  • Enabling the businesses to anticipate market changes and respond proactively
  • Facilitating networking opportunities and relationship-building with stakeholders, where appropriate
  • Supporting business innovation and growth through strategic counsel

Practical information

For more information, please contact us:

Maren Jervell Lund

Senior Advisor, Innovation Norway UK & Ireland

London, UK

Tone Varslot Stave

Head of national export initiative on health and life science, Innovation Norway

Register now

Important conditions

Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.

Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.

Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.